<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">23847265</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>07</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">2044-6055</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2013</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ open</Title>
                <ISOAbbreviation>BMJ Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2013-002857</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">e002857</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Clarithromycin strongly inhibits enzyme cytochrome P450 3A4, preventing the metabolism of some other drugs, while azithromycin is a weak inhibitor. Accordingly, blood concentrations of other drugs increase with clarithromycin coprescription leading to adverse events. These macrolide antibiotics also differ on other properties that may impact outcomes. In this study, we compared outcomes in two groups of macrolide antibiotic users in the absence of potentially interacting drugs.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Population-based retrospective cohort study.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">Ontario, Canada, from 2003 to 2010.</AbstractText>
                <AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients (mean 74 years) prescribed clarithromycin (n=52 251) or azithromycin (referent group, n=46 618).</AbstractText>
                <AbstractText Label="MAIN OUTCOMES" NlmCategory="RESULTS">The primary outcomes were hospital admission within 30 days of a new antibiotic prescription with any of the 12 conditions examined separately (acute kidney injury, acute myocardial infarction, neuroimaging (proxy for delirium), hypotension, syncope, hyperkalaemia, hyponatraemia, hyperglycaemia, arrhythmia, ischaemic stroke, gastrointestinal bleeding and sepsis). The secondary outcome was mortality.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The baseline characteristics of the two groups, including patient demographics, comorbid conditions, infection type and prescribing physician specialty, were nearly identical. The median daily dose was 1000 mg for clarithromycin and 300 mg for azithromycin and the median duration of dispensing antibiotics was 10 and 5 days, respectively. There was no difference between the groups in the risk of hospitalisation for any condition studied (relative risk ranged from 0.67 to 1.23). Compared with azithromycin, clarithromycin was associated with a slightly higher risk of all-cause mortality (0.46% vs 0.37%, relative risk 1.25, 95% CI 1.03 to 1.52).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clarithromycin can be used to assess drug interactions in population-based studies with azithromycin serving as a control group. However, any differences in mortality observed between the two antibiotic groups in the setting of other drug use may be partially attributable to factors beyond the inhibition of drug metabolising enzymes and transporters, as the difference for this outcome was significant.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fleet</LastName>
                    <ForeName>Jamie L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Nephrology, Department of Medicine, Western University, London, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shariff</LastName>
                    <ForeName>Salimah Z</ForeName>
                    <Initials>SZ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bailey</LastName>
                    <ForeName>David G</ForeName>
                    <Initials>DG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gandhi</LastName>
                    <ForeName>Sonja</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Juurlink</LastName>
                    <ForeName>David N</ForeName>
                    <Initials>DN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nash</LastName>
                    <ForeName>Danielle M</ForeName>
                    <Initials>DM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mamdani</LastName>
                    <ForeName>Muhammad</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gomes</LastName>
                    <ForeName>Tara</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Amit M</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Garg</LastName>
                    <ForeName>Amit X</ForeName>
                    <Initials>AX</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Open</MedlineTA>
            <NlmUniqueID>101552874</NlmUniqueID>
            <ISSNLinking>2044-6055</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Clinical Pharmacology</Keyword>
            <Keyword MajorTopicYN="N">Preventive Medicine</Keyword>
            <Keyword MajorTopicYN="N">Public Health</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23847265</ArticleId>
            <ArticleId IdType="pii">bmjopen-2013-002857</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjopen-2013-002857</ArticleId>
            <ArticleId IdType="pmc">PMC3710981</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Kidney Int. 2012 Oct;82(8):903-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22695327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 2006 Mar;62(3):203-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16416302</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2013 Jun 18;158(12):869-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23778904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Metab Dispos. 2007 May;35(5):779-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17296622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>West J Med. 1994 Jan;160(1):31-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8128699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Rheumatol. 2009 Sep;15(6):303-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19734738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gen Med. 2012;5:283-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22505827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Rev. 2011 Mar;63(1):157-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21245207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1986 Feb 8;1(8476):307-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2868172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2012 Jun;81(12):1248-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22437415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2006 Dec;80(6):565-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17178259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Saf. 2009;32(2):159-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19236122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nucl Med. 2004 Dec;29(12 ):803-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15545884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chronic Dis. 1987;40(5):373-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3558716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 1993 Jun;31 Suppl E:153-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8396087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2007 Oct 16;147(8):573-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17938396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Clin Pharmacol. 2003 Summer;10(2):67-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12879144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2002 Apr;45(4):291-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12030792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2010 May;15(9-10):391-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20211755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2012 May 17;366(20):1881-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22591294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Crit Care Med. 2011 Jul;15(3):182-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22013313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Sep 9;351(11):1089-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15356306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prescrire Int. 2012 Jul;21(129):182</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22852287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 1991 Sep;19 Suppl A:29-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1684980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2000 Jan;38(1):41-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10668858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 1993 Jun;31 Suppl E:137-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8396085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Can J Cardiol. 2011 Nov-Dec;27(6):870.e15-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21907534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2011 Feb 22;183(3):303-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21242274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2005 Apr 23;330(7497):960-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15845982</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs Aging. 2012 Mar 1;29(3):205-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22372724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2005 May 26;352(21):2211-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15917386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2012 Apr 17;156(8):560-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22508733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2000 Oct;50(4):285-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11012550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2013 Mar 5;185(4):309-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23184849</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>